PHARMACOLOGICAL CHAPERONES. NEW THERAPEUTIC ALTERNATIVE FOR FABRY DISEASE NEPHROPATY IN ARGENTINA

被引：0
作者：
Jaurretche, Sebastian [1 ,2 ]
机构：
[1] Inst Univ Italiano Rosario, Catedra Biofis & Fisiol Humana, Rosario, Santa Fe, Argentina
[2] Sanatorio Parque, Serv Trasplante & Renopancreas, Rosario, Santa Fe, Argentina
来源：
REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE | 2020年 / 40卷 / 01期
关键词：
ENZYME REPLACEMENT THERAPY; ALPHA-GALACTOSIDASE; RENAL-FUNCTION; CYSTATIN-C; BIOMARKERS; FEMALES; GLOBOTRIAOSYLSPHINGOSINE; PROGRESSION; POPULATION; PREVALENCE;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / 61
页数：11
相关论文
共 64 条
[1]   Pathogenesis of Fabry nephropathy: The pathways leading to fibrosis [J].
Adriana Rozenfeld, Paula ;
de los Angeles Bolla, Maria ;
Quieto, Pedro ;
Pisani, Antonio ;
Feriozzi, Sandro ;
Neuman, Pablo ;
Bondar, Constanza .
MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) :132-141
[2]   Elevated globotriaosylsphingosine is a hallmark of Fabry disease [J].
Aerts, Johannes M. ;
Groener, Johanna E. ;
Kuiper, Sijmen ;
Donker-Koopman, Wilma E. ;
Strijland, Anneke ;
Ottenhoff, Roelof ;
van Roomen, Cindy ;
Mirzaian, Mina ;
Wijburg, Frits A. ;
Linthorst, Gabor E. ;
Vedder, Anouk C. ;
Rombach, Saskia M. ;
Cox-Brinkman, Josanne ;
Somerharju, Pentti ;
Boot, Rolf G. ;
Hollak, Carla E. ;
Brady, Roscoe O. ;
Poorthuis, Ben J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (08) :2812-2817
[3]   New biomarkers defining a novel early stage of Fabry nephropathy: A diagnostic test study [J].
Aguiar, Patricio ;
Azevedo, Olga ;
Pinto, Rui ;
Marino, Jacira ;
Baker, Robert ;
Cardoso, Carlos ;
Ducla Soares, Jose Luis ;
Hughes, Derralynn .
MOLECULAR GENETICS AND METABOLISM, 2017, 121 (02) :162-169
[4]  
[Anonymous], 2019, INT J CHRON DIS
[5]  
[Anonymous], CASE REP NEPHROL
[6]  
[Anonymous], 2006, Fabry Disease: Perspectives from 5 Years of FOS
[7]  
Asano N, 2000, EUR J BIOCHEM, V267, P4179
[8]   Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease [J].
Barbey, Frederic ;
Brakch, Noureddine ;
Linhart, Ales ;
Jeanrenaud, Xavier ;
Palecek, Thomas ;
Bultas, Jan ;
Burnier, Michel ;
Hayoz, Daniel .
ACTA PAEDIATRICA, 2006, 95 :63-68
[9]   When Foots Come First: Early Signs of Podocyte Injury in Fabry Nephropathy Without Proteinuria [J].
Becherucci, Francesca ;
Romagnani, Paola .
NEPHRON, 2015, 129 (01) :3-5
[10]   The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat [J].
Benjamin, Elfrida R. ;
Della Valle, Maria Cecilia ;
Wu, Xiaoyang ;
Katz, Evan ;
Pruthi, Farhana ;
Bond, Sarah ;
Bronfin, Benjamin ;
Williams, Hadis ;
Yu, Julie ;
Bichet, Daniel G. ;
Germain, Dominique P. ;
Giugliani, Roberto ;
Hughes, Derralynn ;
Schiffmann, Raphael ;
Wilcox, William R. ;
Desnick, Robert J. ;
Kirk, John ;
Barth, Jay ;
Barlow, Carrolee ;
Valenzano, Kenneth J. ;
Castelli, Jeff ;
Lockhart, David J. .
GENETICS IN MEDICINE, 2017, 19 (04) :430-438
1234567